R&D How breath analysis could help those living with gut health ... It has been estimated that 12% of the UK population suffer from irritable bowel syndrome (IBS), an umbrella term that describes a bro
News Chiesi backs growth plans with a €430m new plant in Italy Fast-growing pharma group Chiesi has revealed plans to spend €430m on a new therapeutics manufacturing facility at its site in Milan.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl